Amgen Settles 12th Sensipar Patent Fight
Emcure Pharmaceuticals Ltd. and its subsidiary Heritage Pharmaceuticals Inc. have agreed to hold off on a generic version of Amgen Inc.'s blockbuster calcium reducer Sensipar, which is at least the 12th such...To view the full article, register now.
Already a subscriber? Click here to view full article